Short tandem repeat profiling is the most validated method to confirm cell line identity and avoid misidentified or cross-contaminated cell lines.
Fang Tian
Advertisement
Fang Tian, PhD, is lead scientist, Cell Biology, ATCC; ftian@atcc.org.
Articles by Fang Tian
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
2
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
3
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
4
After the Pivot: What In Vivo Cell Therapy Offers, and What It Still Has to Prove
5